Related Experiment Video

Updated: Aug 7, 2026

Protocols for Robust Herbicide Resistance Testing in Different Weed Species
10:52

Protocols for Robust Herbicide Resistance Testing in Different Weed Species

Published on: July 2, 2015

Taxol resistance

S Sangrajrang1, A Fellous

  • 1Research Division, National Cancer Institute, Bangkok, Thailand. sulee@health.moph.go.th

Chemotherapy
|August 31, 2000
PubMed
Abstract

Insights

Tumors can develop resistance to Taxol, a cancer drug, through multiple adaptations. Understanding these mechanisms, particularly changes in microtubules, is crucial for improving cancer treatment strategies.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Taxol is a widely used chemotherapy agent for various cancers, including breast, ovarian, and lung.
  • Acquired drug resistance in tumors remains a significant challenge in achieving a complete cancer cure.
  • Investigating Taxol resistance mechanisms is vital for developing more effective cancer therapies.

Purpose of the Study:

  • To review current knowledge on Taxol's effects and the development of tumor resistance.
  • To focus on the role of microtubule alterations in Taxol resistance.

Main Methods:

  • Literature review of existing preclinical and clinical data.
  • Analysis of studies focusing on Taxol and drug resistance mechanisms.
  • Emphasis on alterations in microtubules.

Main Results:

  • Tumor resistance to Taxol is a multifactorial process involving various cellular adaptations.
  • Cellular transport mechanisms play a role in Taxol resistance.
  • Alterations in microtubule dynamics are implicated in Taxol resistance.

Conclusions:

  • Multiple adaptations contribute to acquired Taxol resistance.
  • While cellular transport is important, changes in microtubule transcription and posttranslational modification are key to resistance.
  • Further research into these mechanisms can inform novel therapeutic strategies against Taxol-resistant cancers.

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...